Evidence map›Paper›PMID 28868207›Full record

ArticleNature biomedical engineering2017

Host non-inflammatory neutrophils mediate the engraftment of bioengineered vascular networks.

Ruei-Zeng Lin, Chin Nien Lee, Rafael Moreno-Luna, Joseph Neumeyer, Breanna Piekarski, Pingzhu Zhou, Marsha A Moses, Monisha Sachdev, William T Pu, Sitaram Emani and 1 more

Abstract read
In one paragraph

Article in Nature biomedical engineering, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ruei-Zeng LinDepartment of Cardiac Surgery, Boston Children's Hospital, Boston, MA 02115, USA.
Chin Nien LeeDepartment of Cardiac Surgery, Boston Children's Hospital, Boston, MA 02115, USA.
Rafael Moreno-LunaDepartment of Cardiac Surgery, Boston Children's Hospital, Boston, MA 02115, USA.
Joseph NeumeyerDepartment of Cardiac Surgery, Boston Children's Hospital, Boston, MA 02115, USA.
Breanna PiekarskiDepartment of Cardiac Surgery, Boston Children's Hospital, Boston, MA 02115, USA.
Pingzhu ZhouDepartment of Cardiology, Boston Children's Hospital, Boston, MA 02115, USA.
Marsha A MosesDepartment of Surgery, Harvard Medical School, Boston, MA 02115, USA.
Monisha SachdevVascular Biology Program, Boston Children's Hospital, Boston, MA 02115, USA.
William T PuDepartment of Cardiology, Boston Children's Hospital, Boston, MA 02115, USA.
Sitaram EmaniDepartment of Cardiac Surgery, Boston Children's Hospital, Boston, MA 02115, USA.
Juan M Melero-MartinDepartment of Cardiac Surgery, Boston Children's Hospital, Boston, MA 02115, USA.

Funding

VectorP30CA006516 · NCI · DANA-FARBER CANCER INSTITUTE · PI A. Heather Eliassen · 1985 to 2026
$330.6M
Vascular networks genetically engineered for protein drug deliveryR01HL128452 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI MELERO-MARTIN, JUAN M, WANG, BO · 2015 to 2024
$4.8M
Vascular niche bioengineering for human bone regenerationR01AR069038 · NIAMS · BOSTON CHILDREN'S HOSPITAL · PI MELERO-MARTIN, JUAN M · 2016 to 2020
$1.9M
Engineering vascularized tissue in vivo using postnatal progenitor cellsR00EB009096 · NIBIB · BOSTON CHILDREN'S HOSPITAL · PI MELERO-MARTIN, JUAN M · 2011 to 2013
$719k
Host neutrophils as direct mediators of tissue graft revascularizationR21AI123883 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI MELERO-MARTIN, JUAN M · 2016 to 2017
$487k
NCI NIH HHS P30 CA006516NHLBI NIH HHS R01 HL128452NIAID NIH HHS R21 AI123883NIAMS NIH HHS R01 AR069038NIBIB NIH HHS R00 EB009096
6 · The paper itself

Abstract

Notwithstanding remarkable progress in vascular network engineering, implanted bioengineered microvessels largely fail to form anastomoses with the host vasculature. Here, we demonstrate that implants containing assembled human vascular networks (A-Grafts) fail to engraft due to their inability to engage non-inflammatory host neutrophils upon implantation into mice. In contrast, unassembled vascular cells (U-Grafts) readily engage alternatively polarized neutrophils, which in turn serve as indispensable mediators of vascular assembly and anastomosis. The depletion of host neutrophils abrogated vascularization in U-Grafts, whereas an adoptive transfer of neutrophils fully restored vascularization in myeloid-depleted mice. Neutrophil engagement was regulated by secreted factors and was progressively silenced as the vasculature matured. Exogenous addition of factors from U-Grafts reengaged neutrophils and enhanced revascularization in A-Grafts, a process that was recapitulated by blocking Notch signaling. Our data suggest that the pro-vascularization potential of neutrophils can be harnessed to improve the engraftment of bioengineered tissues.

Identifiers

PMID28868207
PMCPMC5578427

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.